Maia Biotechnology
Clinical trials sponsored by Maia Biotechnology, explained in plain language.
-
New drug combo aims to revive immune System's fight against advanced lung cancer
Disease control Recruiting nowThis study is for adults with advanced non-small cell lung cancer that has worsened after two prior treatments, including immunotherapy and chemotherapy. It compares a new two-drug combination (THIO followed by cemiplimab) against standard chemotherapy. The goal is to see if the …
Phase: PHASE3 • Sponsor: Maia Biotechnology • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo aims to Re-Sensitize tough lung cancers to immunotherapy
Disease control Recruiting nowThis study is testing a new drug called THIO, given before an immunotherapy drug (cemiplimab), for people with advanced non-small cell lung cancer. It is for patients whose cancer has continued to grow or returned after their first treatment that included an immunotherapy drug. T…
Phase: PHASE2 • Sponsor: Maia Biotechnology • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC